Print

Cyclacel Pharmaceuticals, Inc. (CYCC) to Present at Lazard Healthcare Conference  
11/7/2012 9:19:23 AM

BERKELEY HEIGHTS, N.J., Nov. 7, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, announced today that Spiro Rombotis, President and Chief Executive Officer, will present at the Lazard Capital Markets 9th Annual Healthcare Conference at The Pierre Hotel in New York City. Cyclacel's presentation will take place on Tuesday, November 13th at 9:00 a.m. Eastern Time.
//-->